REPRESENTATIVE TRANSACTIONS

M2M Spectrum Networks
http://m2mspectrum.com/M2M Spectrum Networks is the first company to provide comprehensive solutions for creating, connecting and managing machine-to-machine (M2M) communications for The Internet
of Things (IoT).

PeerNova, Inc.
http://peernova.com/PeerNova has developed the first immutable ledger with built-in audit, control, scale, and other capabilities necessary to help the world’s most trusted organizations store, secure, and validate their data.

ViewRay, Inc. (OTCQB: VRAY)
http://www.viewray.comViewRay has built and sells the first and only MRI-guided radiation therapy system that images and treats cancer patients simultaneously.

Pieris Pharmaceuticals, Inc.
(NASDAQ: PIRS)
http://www.pieris.com/Pieris is a biopharmaceutical company engaged in the discovery and development of Anticalins®, a novel class of targeted human proteins designed to diagnose and treat serious human disorders.

Enumeral Biomedical Holdings, Inc. (OTCQB: ENUM)
http://www.enumeral.com/Enumeral is discovering and developing novel antibody therapeutics that help the immune system attack diseased cells. By using their proprietary platform, they have a unique ability to extensively interrogate cells of the human immune system for drug candidate validation and that this ability, gives them a distinct advantage in selecting potential best-in-class therapeutic candidates.

CÜR Media, Inc. (OTCQB: CURM)
http://www.curmusic.com/CÜR is a new streaming music experience that intersects the mass market between Pandora and Spotify for listening to music on the web and mobile devices. CÜR is a low-cost music subscription service that is focused on delivering a Music Access 2.0 product with a toolset for curating and sharing.

Ekso Bionics, Inc. (OTCQB: EKSO)
http://eksobionics.comEkso Bionics, Inc. has pioneered the field of robotic exoskeletons to augment human strength, endurance and mobility. The Company is developing and manufacturing wearable robots, or “exoskeletons,” that have a variety of applications in the medical, industrial, military and consumer markets.

Ostendo Technologies, Inc.
http://www.ostendo.com/Ostendo has developed a breakthrough emissive micro-display technology to address the next generation visual communication needs to enable intuitive, interactive, and immersive experiences. The core device is referred to as Quantum Photonic Imager or QPI® and is being integrated into ultra-compact projector devices and 3D holographic display systems.

Neurotrope, Inc. (OTCQB:NTRP)
http://www.neurotropebioscience.comNeurotrope is a clinical stage biopharmaceutical and diagnostics company in the neurological clinical sciences that has compelling, novel and proprietary assets that are extremely encouraging for the diagnosis and treatment of Alzheimer’s Disease. The company has exclusive licenses to a broad portfolio of drug discovery data, technologies, and putative drug prototypes from the Blanchette Rockefeller Neuroscience Institute (BRNI) and its subsidiaries.

QuantiaMD (Acquired by Physicians Interactive)
https://quantiamd.comQuantiaMD is a vibrant clinical exchange that is fast becoming the center of activity between physicians and the organizations shaping healthcare.

Etubics Corporation
http://www.etubics.comEtubics Corporation is a clinical stage bio-pharmaceutical company, which has developed a proprietary immunization platform technology. The Etubics immunization and treatment processes are simple-to-use injectables, which compare favorably to other vaccine products in the marketplace.

Violin Memory, Inc. (NYSE: VMEM)
www.violin-memory.comViolin Memory is pioneering the future of Flash memory in the enterprise data center with Memory Arrays that accelerate business critical applications and enable enterprises to virtualize and optimize their IT infrastructures. Specifically designed for sustained performance with high reliability, Violin’s Memory Arrays scale to hundreds of terabytes and millions of IOPS with low, spike-free latency.

InterAct911 (Acquired by Constellation Software Inc.)
www.interact911.comInterAct Public Safety is a leading provider of public safety incident response and management software. The Company provides integrated multi-agency, multi-jurisdictional public safety, corporate security, and homeland security systems technology.

BeneChill, Inc.
www.benechill.comNGN Capital and HealthCap.
BeneChill, Inc., is an innovative medical device company that has developed a device to deliver therapeutic hypothermia to the brain. The Company is developing a non-invasive cooling technology for treatment following ischemic stroke, cardiac arrest or traumatic brain injury.

Calient Technologies, Inc.
www.calient.netCALIENT Technologies is the proven leader in 3D MEMS Technology. The technology is based on its patented deep-silicon plasma etch process that is used to make 3D MEMS mirrors. With this process, the company is able to develop products that lead the industry in performance and manufacturing cost.

eASIC Inc.
www.easic.comeASIC is a fables semiconductor company that has a proven, disruptive breakthrough technology which adds significant value to their customers by reducing the overall cost and time associated with the production of customized semiconductor devices.

Certes Networks, Inc.
www.certesnetworks.comCertes Networks (formerly CipherOptics) is the leader in developing scalable security solutions for high performance networks. They provide advanced encryption and policy and key management solutions for securing wide area networks, and enable secure connectivity to private and public clouds.

Percutaneous Systems, Inc.
www.percsys.comPercSys is focused on developing and commercializing devices that make endourologic kidney stone procedures easier, less traumatic, and more effective therapeutically. While the company's current devices influence outcomes of minimally invasive procedures performed in the operating room, devices in the pipeline and clinical efforts expand the company's reach into external, and eventually in-office, stone intervention.

My Damn Channel, Inc.
www.mydamnchannel.comMy Damn Channel creates premium, branded entertainment and guarantees audience delivery for partners like HBO, Puma, Trident Layers, Southern Comfort, IKEA, and Lincoln. The Company empowers comedians, actors, filmmakers, musicians and brands to co-produce, distribute and monetize original video. Artists create content for the My Damn Channel website and for syndication on all digital platforms.

Shea Ventures Opportunity Fund
www.jfshea.comWe have provided our clients access to invest in Shea Ventures Opportunity Fund, which invests in late-stage venture-backed companies by providing liquidity in secondary direct transactions. In these transactions Shea Ventures is acquiring interests from existing shareholders in venture-backed companies who are seeking liquidity. The fund may also acquire interests in mature venture capital limited partnerships.
Testimonials
Intuitive Venture Partners was instrumental in conducting an effective transaction process that ultimately led to our closing a convertible debt financing. Intuitive VP achieved a closing on time and on target in a difficult market and I would not hesitate to use the firm again for other transactions.
- Dr. Frank R. Jones, Chairman and Chief Executive Officer, Etubics Corporation
It was a pleasure to work with the Intuitive Venture Partners Team in support of InterAct’s “C” Round. Intuitive delivered to their commitments, on time and target! They are a highly focused, committed and professional Team that I highly recommend.
- John McNulty, President & CEO, InterAct™
Intuitive Venture Partners are every mature start-up company’s dream. They have an extensive and accomplished network of investors, they raise the money promised in no time, and they remain attentive to the company’s every need beyond the raise. To top it all, they are an absolute pleasure to work with.
- Denise Barbut MD MRCP, Founder & Chairman, BeneChill, Inc.
Intuitive Partners led our round of financing in an expeditious manner. They were able to attract new and knowledgeable investors to our syndicate through their extensive client network and with minimal time required from our team.
- Ronnie Vasishta, President & CEO, eASIC, Inc.
Intuitive Venture Partners far exceeded my expectations for this round of financing for Calient. This group delivered on every promise and did so with the upmost professionalism and integrity. Their network of investors will be extremely valuable to us. I look forward to a long term relationship with them.
- Atiq Raza, Chairman & CEO, Calient Technologies, Inc.
Intuitive Venture Partners did an excellent job on the Calient financing. They exceeded our expectations on amount, timing and execution! We look forward to working with them on many more projects in the future.
- Arjun Gupta, Founder & Managing Partner, TeleSoft Partners
We were very pleased with the efficiency and professionalism that Intuitive Venture Partners demonstrated during our fund raising engagement. They did a thorough evaluation of our company. Their industry contacts will be highly beneficial to us as we begin to invest the proceeds of our newly closed financing round. Intuitive Venture Partners delivered everything as promised and more.
- Thomas J. Gill, Chairman & CEO, Certes Networks, Inc.
Intuitive Venture Partners delivered on the financing for our company right on schedule. They are superbly organized, professional, and work hard to deliver on their promises. - Robert Behl, Founder & Chairman, Percutaneous Systems, Inc.
Intuitive Venture Partners proved to be one of the most professional teams we have worked with at My Damn Channel. They have an extraordinary track record of success in the capital markets and they bring an impressive network of industry advisors and potential partners to the table. - Rob Barnett, CEO, My Damn Channel.
Intuitive Venture Partners is a dedicated group of professionals who have been a great co-investor with us. They exceeded our expectations and we look forward to working with them again. - Jason Schoettler, Managing Director, Shea Ventures.